美国间歇性跛行患者监督运动疗法可及性与使用情况全国评估
该研究通过向美国900名血管外科医生、心脏病专家和血管医学医生发放8题在线调查,并回顾近两年主要血管外科会议摘要,评估监督运动疗法(SET)的可及性、对CMS覆盖的认知及学术关注。
要点
- 多数机构无SET项目,且SET多附属于心脏康复而非PAD专用。
- 若SET可用,98%医生表示愿意转诊,但可及性和费用是主要障碍。
核心结论
- 尽管指南推荐SET为一线治疗且CMS已覆盖,美国PAD伴跛行患者中SET的可及性和使用率仍不足。
研究设计与样本
- 向美国900名血管外科医生、心脏病专家和血管医学医生发放8题在线调查,回收135份(15%),覆盖全美50州;并回顾近两年四大血管会议摘要以评估学术关注。
主要发现
- 54%的应答者表示所在机构无SET项目,5%不清楚是否有;有SET项目的机构中81%附属于心脏康复,19%为PAD专用。
- 98%的应答者表示若SET可用愿意转诊;主要障碍为无SET中心及患者费用/交通负担。
- 近两年主要血管外科会议无SET相关摘要。
临床怎么用
- 血管外科医生应主动了解并转诊患者至SET项目,尤其需关注CMS覆盖信息。
- 推动建立PAD专用SET项目,并解决费用和交通障碍以提高使用率。
局限性
- 调查应答率仅15%,可能存在无应答偏倚。
- 会议摘要回顾仅限四个会议近两年,可能遗漏其他学术来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Supervised exercise therapy (SET) is an inexpensive, low-risk, and effective option when compared with invasive therapies for the treatment of patients with peripheral artery disease (PAD) and intermittent claudication. Randomized, controlled trials have demonstrated the benefits of SET in improving maximum walking distance in intermittent claudication patients, and society guidelines recommend SET as first-line therapy. In 2017, the Centers for Medicare & Medicaid Services (CMS) added coverage of SET. We aimed to evaluate the availability and use of SET programs, determine the awareness of SET CMS coverage in the United States, and gauge the academic interest in SET in the vascular community. METHODS: An eight-question online survey regarding SET coverage, reimbursement, barriers to prescription, and SET use was sent to 900 vascular surgeons, cardiologists, and vascular medicine physicians across the United States. The most recent 2-year programs for the Vascular Annual Meeting, Midwestern Vascular Society, Eastern Vascular Society, and Western Vascular Society were reviewed to identify SET-related abstracts and gauge academic interest and awareness for SET within the vascular surgery community. RESULTS: We received 135 physician responses (15%) to the survey. All 50 states were represented. The majority of responders (54%) stated that there was no SET program at their facility, and 5% did not know if there was a SET program available. Of those who did have a SET program available, 81% were associated with cardiac rehabilitation and 19% had a PAD-specific program. A significant number of physicians (49%) had never referred a patient for SET. Twenty-six percent were not aware that CMS covered SET sessions. Of the physicians who were aware of CMS reimbursement, 36% had never referred a patient to a SET program. Of all surveyed, 98% indicated they would refer patients to a SET program if one was available. Top barriers to use of a SET program included (1) no SET center availability and (2) significant cost or travel expense to the patient. A review of major vascular surgery meeting programs for the last 2 years yielded no identification of a SET-related abstract. CONCLUSIONS: There is a lack of both availability and use of SET for patients with PAD with claudication, despite guideline recommendations and CMS reimbursement for SET sessions in the United States. When SET is offered, it is typically through cardiac rehabilitation programs which is not focused on PAD. Travel distance, lack of SET program availability, and low reimbursement rates are primary areas that could be addressed to improve use.
引用
- Dua A, Gologorsky R, Savage D, et al. National assessment of availability, awareness, and utilization of supervised exercise therapy for peripheral artery disease patients with intermittent claudication. J Vasc Surg. 2019. PMID: 31699514. doi:10.1016/j.jvs.2019.08.238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。